Cite
HARVARD Citation
Keystone, E. et al. (n.d.). AB0461 Long-term use of adalimumab as monotherapy following attainment of low-disease activity: Subanalysis of the open-label extension of premier. Annals of the rheumatic diseases. p. 664. [Online].